Zero ad trackers.We never sell your data.Healthcare professional?Clinician Resources

Pulmonary Langerhans Cell Histiocytosis Clinical Trials Near Me

As of November 13, 2026, 13 Pulmonary Langerhans Cell Histiocytosis clinical trials are recruiting now and 1 is not yet recruiting. In the US, 5 of them have at least 1 open site, across 12 states and Washington, DC. Enter your ZIP code below to see which are closest to you.

Also on Trial Friend:Pulmonary Langerhans Cell Histiocytosis pageMatch Me

Trial Friend never receives or stores your ZIP code. Your browser looks up its location with a free map service.
Distance
Status
Ages
Phase
A study site. Select it to see its trials and get directions. Several sites close together. Select the number to zoom in.
+14 more

All 13 Pulmonary Langerhans Cell Histiocytosis trials and their US sites

Enter your ZIP code above to sort them by how far their nearest open site is from you.

  1. Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
    Most sites in California, Texas and Arizona
    RecruitingPhase 2Carl Allen
    11US sites
    9 states
  2. Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
    Most sites in Texas, California and Ohio
    RecruitingPhase 3Up to age 21Baylor College of Medicine
    10US sites
    5 states
  3. Histiocytic Disorder Follow-up Study
    Only in Alabama
    RecruitingAges 0-89University of Alabama at Birmingham
    1US site
  4. Mirdametinib in Histiocytic Disorders
    Only in Ohio
    RecruitingPhase 2Ages 2+Children's Hospital Medical Center, Cincinnati
    1US site
  5. Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, Trametinib
    Only in Texas
    RecruitingPhase 2Ages 1-30Cook Children's Health Care System
    1US site
  6. Adult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort Study
    RecruitingAges 18+Assistance Publique - Hôpitaux de Paris
    No US site yet
  7. Biomarkers for Diagnostic, Prognostic and of Response to Treatment in Adult Langerhans Cell Histiocytosis
    RecruitingAges 18+Assistance Publique - Hôpitaux de Paris
    No US site yet
  8. DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
    RecruitingPhase 2/3Ages 1+Cancer Research UK
    No US site yet
  9. Efficacy and Safety of Low-Dose Cytarabine Combined With Thalidomide in Adult Patients With Untreated LCH
    RecruitingPhase 2Ages 18-70Cancer Institute and Hospital, Chinese Academy of Medical Sciences
    No US site yet
  10. Luvometinib in Pediatric SS-LCH With Special-site Single/Multifocal Bone Lesions
    RecruitingAges 0-18West China Second University Hospital
    No US site yet
  11. Modified LCH-III Regimen With or Without Luvometinib for Multisystem Pediatric Langerhans Cell Histiocytosis
    RecruitingAges 0-18West China Second University Hospital
    No US site yet
  12. Real-world Study of Darafenib or Trametinib and Clofarabine for High-risk/Recurrent/Refractory Langerhans Cell Histiocytosis in Children
    RecruitingPhase 2Ages 0-18West China Second University Hospital
    No US site yet
  13. To Evaluate the Efficacy, Safety, and PK Characteristics of FCN-159 in Pediatric Patients With Refractory/Recurrent LCH
    RecruitingPhase 2Ages 2-16Shanghai Fosun Pharmaceutical Industrial Development Co.
    No US site yet
Get an email when Pulmonary Langerhans Cell Histiocytosis trials change

New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.

You'll get, for Pulmonary Langerhans Cell Histiocytosis:
  • Trial Alerts, when a new trial opens or a trial changes
  • Disease Updates, FDA decisions and condition news, usually 1 or 2 emails a month
Turn either off anytime from the link in every email.
We never share your email. Unsubscribe anytime. Privacy policy · Check any health site

Who runs the Pulmonary Langerhans Cell Histiocytosis trials in the US, and what stage they are in

Of the 5 Pulmonary Langerhans Cell Histiocytosis trials with a US site, 1 is in Phase 3, the last stage before a company can ask the FDA for approval. Earlier Phase 1 or 2 tests of safety and dosing make up 3 of them. The last one has no drug phase, such as a study that follows people over time or tests a device or a way of giving care. Universities, hospitals, foundations and government groups run all of them, with no company leading one. The most recently listed one first appeared on ClinicalTrials.gov on September 3, 2024.

Pulmonary Langerhans Cell Histiocytosis trials in the US, state by state

All 5 Pulmonary Langerhans Cell Histiocytosis trials with a US site accept children under 18. Their open sites are in 12 states and Washington, DC, most often Texas, California and Ohio. A trial counts once in each state where it has an open site, and some trials accept both children and adults.

StateTrialsChildrenAdultsCities with the most
Texas333Fort Worth (2), Houston (2), Austin (1), plus 3 more
California222Orange (1), Palo Alto (1), San Diego (1), plus 1 more
Ohio222Cincinnati (1), Columbus (1)
Alabama111Birmingham (1)
Arizona111Phoenix (1)
Arkansas111Little Rock (1)
District of Columbia111Washington D.C. (1)
Maryland111Baltimore (1)
Massachusetts111Boston (1)
New York111New York (1)
Show the other 3 states
Pennsylvania111Allentown (1)
Tennessee111Memphis (1)
Virginia111Norfolk (1)

US hospitals running the most Pulmonary Langerhans Cell Histiocytosis trials

Centers that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Pulmonary Langerhans Cell Histiocytosis.

  1. Cook Children's Health Care SystemFort Worth, Texas2 trials
  2. Texas Children's HospitalHouston, Texas2 trials
  3. Arkansas Children's HospitalLittle Rock, Arkansas1 trial
  4. Children's Hospital of Orange CountyOrange, California1 trial
  5. Children's Hospital of San AntonioSan Antonio, Texas1 trial
  6. Children's Hospital of The King's DaughtersNorfolk, Virginia1 trial
  7. Children's Medical Center- UTSWDallas, Texas1 trial
  8. Children's National HospitalWashington D.C., District of Columbia1 trial
  9. Cincinnati Children's Hospital Medical CenterCincinnati, Ohio1 trial
  10. Dana Farber Cancer Institute, Boston Children'sBoston, Massachusetts1 trial

Help getting to a Pulmonary Langerhans Cell Histiocytosis trial far from home

Ask the study team whether the trial pays back travel, parking and hotel costs, because many sponsors do. The FDA's guidance on paying research volunteers says paying back these costs does not count as pressuring someone to join.

These nonprofits also help patients reach care, and each one sets its own rules.

Mercy Medical Angels
Pays for gas cards, ground rides and airline tickets anywhere in the US, and it lists clinical trials as a reason to travel. Household income at or below 300% of the federal poverty guidelines, and usually a trip of 50 miles or more each way.
Air Charity Network
Volunteer pilots in all 50 states fly patients for free in small private planes, and members also fly people taking part in clinical trials. You must be able to walk and sit upright for the flight, show financial need and have a backup plan if weather cancels it.
Ronald McDonald House
Gives families a room near the hospital while a child gets care, through 394 House programs around the world. Families of a sick child, with rules set by each local chapter.
Healthcare Hospitality Network
Keeps a map of hospitality houses near hospitals, and most member houses charge little or nothing to patients and families. Each house sets its own rules, so check with the house near your study site.

Program details were checked on each program's website on October 24, 2026.

Questions about finding a Pulmonary Langerhans Cell Histiocytosis trial near you

Are there Pulmonary Langerhans Cell Histiocytosis clinical trials near me?

As of November 13, 2026, 13 Pulmonary Langerhans Cell Histiocytosis clinical trials are recruiting now and 1 is not yet recruiting. In the US, 5 of them have at least 1 open site, across 12 states and Washington, DC. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.

Which states have Pulmonary Langerhans Cell Histiocytosis clinical trial sites?

Recruiting Pulmonary Langerhans Cell Histiocytosis trials list open sites in 12 states and Washington, DC. Texas, California and Ohio have the most, and the table on this page lists every state.

Are there Pulmonary Langerhans Cell Histiocytosis trials for children near me?

All 5 Pulmonary Langerhans Cell Histiocytosis trials with a US site accept children under 18. Their open sites are in 12 states and Washington, DC, most often Texas, California and Ohio. Each trial sets its own age limits, so check the ages listed on a trial before you contact it.

Who pays for travel to a Pulmonary Langerhans Cell Histiocytosis clinical trial?

Many trial sponsors pay back travel, parking and hotel costs, so ask the study team before you rule out a far-away site. The FDA's guidance says paying back these costs does not count as pressuring someone to join. Charities such as Mercy Medical Angels and Air Charity Network can also help with rides and flights.

What if there is no Pulmonary Langerhans Cell Histiocytosis trial near me?

Some trials send staff to your home or use a local lab, so fewer visits happen at the study site. You can also sign up on this page to get an email when a Pulmonary Langerhans Cell Histiocytosis trial opens a new site or changes status.

How is the distance to a trial site measured?

Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.

Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of November 13, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out. Children means the trial's age group includes people under 18.